tirzepatide from eli lilly FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Explained: Marketed

Nursing Facilities: Are Conditions Improving or Is the Sky Falling

Oral semaglutide is $289/mo month-to-month (or $249/mo on the 6-month plan)

Key takeaways Switching from tirzepatide (Mounjaro/Zepbound) to semaglutide (Ozempic/Wegovy) is safe, medically valid, and more common than many people realize

From clinical studies and real-world experience, general patterns often look like this: First 48 weeks: Appetite starts to calm down

Hepatitis/Elevated liver enzymes/Jaundice Diabetic retinopathy problems: Changes in vision in those with Type 2 diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy Severe gastrointestinal disease - may cause gastrointestinal disease